Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults

NCT03646799 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes

Interventions

DRUG: CKD-387
DRUG: D484

Sponsor

Chong Kun Dang Pharmaceutical